Sherman Jeffrey W
- SEC CIK
- 0001230482
In the past year, 1 open-market purchase filing worth $25.0K and no sales.
Current role at each company
- LRMR Larimar Therapeutics, Inc.Directoras of May 20, 2026
- XERS Xeris Biopharma Holdings, Inc.Directoras of Aug 29, 2025
- HZNP Horizon Therapeutics Public Ltd CoEVP and Chief Medical Officeras of Oct 6, 2023
- SBBP Strongbridge Biopharma plcDirectoras of Oct 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sherman Jeffrey W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LRMR Larimar Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Sherman Jeffrey WDirector | PPurchase | +5.00K | $5.00 | +$25.0K | New position5.00K after |
XERS Xeris Biopharma Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 (view filing) | Aug 28 | 1 day | Sherman Jeffrey WDirector | SSale | −42.2K | $7.92 | −$334.5K | −16.2%219.2K after | |
| Nov 29, 2023 (view filing) | Nov 27 | 2 days | Sherman Jeffrey WDirector | PPurchase | +5.40K | $1.87 | +$10.1K | New position5.40K after |
HZNP Horizon Therapeutics Public Ltd Co
EVP and Chief Medical Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 (view filing) | Jan 10-11 | 2 days | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −6.74K | $113.08 | −$761.7K | −15.7%36.2K after | 2 lots |
| Jan 6, 2023 (view filing) | Jan 6 | Same day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −5.19K | $113.29 | −$587.6K | −9.5%49.3K after | |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −28.4K | $111.45 | −$3.16M | −25.1%84.4K after | 2 lots |
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −42.0K | $110.02 | −$4.62M | −79.8%10.6K after | |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −46.3K | $110.00 | −$5.09M | −83.5%9.12K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −5.29K | $95.00 | −$502.3K | −36.7%9.12K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −54.8K | $95.00 | −$5.20M | −29.8%128.8K after |